As a result of their partnership with The Chase Group, Genmab has secured a Director, Global Drug Safety and Pharmacovigilance Physician for their team in Copenhagen, Denmark. In this newly created position, the Drug Safety Physician will report to the Vice President, Head of Global Drug Safety, and serve as the safety expert accountable for the global safety strategy and overall safety profile for the assigned Genmab products throughout their lifecycle. A team player with infectious enthusiasm and passion to make a difference, this physician is a perfect fit, bringing a depth of drug safety, pharmacovigilance knowledge, and experience to Genmab’s team. The company has two approved antibodies and a robust clinical and pre-clinical pipeline. Their current trajectory is leading to exciting developments in the treatment of cancer and company growth. The Chase Group is proud to partner, identify, and secure the high caliber talent needed to revolutionize the treatment of cancer and improve the lives of patients around the world. For more information, please contact ken@chasegroup.com.
The Chase Group Secures Director of Drug Safety in Copenhagen/Denmark for Genmab
As a result of their partnership with The Chase Group, Genmab has secured a Director, Global Drug Safety and Pharmacovigilance Physician for their team in Copenhagen, Denmark. In this newly created position, the Drug Safety Physician will report to the Vice President, Head of Global Drug Safety, and serve as the safety expert accountable for the global safety strategy and overall safety profile for the assigned Genmab products throughout their lifecycle. A team player with infectious enthusiasm and passion to make a difference, this physician is a perfect fit, bringing a depth of drug safety, pharmacovigilance knowledge, and experience to Genmab’s team. The company has two approved antibodies and a robust clinical and pre-clinical pipeline. Their current trajectory is leading to exciting developments in the treatment of cancer and company growth. The Chase Group is proud to partner, identify, and secure the high caliber talent needed to revolutionize the treatment of cancer and improve the lives of patients around the world. For more information, please contact ken@chasegroup.com.
The Chase Group Secures New Leader for Informatics & Computational Biology at the Allen Institute for Immunology
Following an extensive search of industry and academic professionals by The Chase Group, the Allen Institute for Immunology welcomes a new Director, Informatics & Computational…
The Chase Group Successfully Completes the Appointment of Carla Poulson as Senior Vice President/Chief Human Resources Officer at Akcea Therapeutics
After a comprehensive executive search that was filled in less than two months, The Chase Group is pleased to announce the placement of Carla Poulson…
The Chase Group Secures Director of Drug Safety in Copenhagen/Denmark for Genmab
As a result of their partnership with The Chase Group, Genmab has secured a Director, Global Drug Safety and Pharmacovigilance Physician for their team in…
Partnership with The Chase Group Results in Successful Placement for Eisai Global Oncology Business Unit
The Chase Group is proud to partner with Eisai and support their human health care mission by securing a strong and agile leader for their…
Aeglea Biotherapeutics Secures Another Executive for their Clinical Development Leadership Team
To support their rapid growth and expanding portfolio of rare disease programs, Aeglea Biotherapeutics retained The Chase Group and successfully secured a new Global Program…
Eli Lilly Cyramza® Team Grows Through Continued Partnership with Chase
Utilizing their knowledge and years of experience recruiting in the life sciences industry, The Chase Group has successfully secured a new Global Senior Medical Advisor,…